Marc Ladanyi
Impact in
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.01%
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 186
- Sarcoma Diagnosis and Treatment 156
- Occupational and environmental lung diseases 30
- Cancer Research 184
- Cancer Genomics and Diagnostics 157
- Co-authors
- Mark G. Kris (83 shared papers)William J. Pao (39 shared papers)Gregory J. Riely (69 shared papers)María Juliana Arcila (83 shared papers)Maureen Frances Zakowski (39 shared papers)Cristina R. Antonescu (49 shared papers)Vincent A. Miller (25 shared papers)Pedram Argani (28 shared papers)
- Journals
- Clinical Cancer Research (75 papers)Journal of Thoracic Oncology (46 papers)Modern Pathology (39 papers)The American Journal of Surgical Pathology (31 papers)JCO Precision Oncology (28 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Marc Ladanyi
732 papers receiving 161.8k citations
Marc Ladanyi's Hit Papers
Peers
Comparison fields: 5 of 214
- Cancer Research 39.9k
- Pulmonary and Respiratory Medicine 62.5k
- Oncology 50.8k
- Pathology and Forensic Medicine 16.7k
- Molecular Biology 61.9k
Countries citing papers authored by Marc Ladanyi
This map shows the geographic impact of Marc Ladanyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Ladanyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Ladanyi more than expected).
Fields of papers citing papers by Marc Ladanyi
This network shows the impact of papers produced by Marc Ladanyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Ladanyi. The network helps show where Marc Ladanyi may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Ladanyi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 750 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways Hit paper breakdown → | 2008 | 6384 |
| 2 | Integrated genomic analyses of ovarian carcinoma Hit paper breakdown → | 2011 | 6345 |
| 3 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 4 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 5 | The landscape of somatic copy-number alteration across human cancers Hit paper breakdown → | 2010 | 3151 |
| 6 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 7 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Hit paper breakdown → | 2017 | 2650 |
| 8 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 9 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 10 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2442 |
| 11 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 12 | Comprehensive molecular characterization of urothelial bladder carcinoma Hit paper breakdown → | 2014 | 2419 |
| 13 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 14 | Somatic mutations affect key pathways in lung adenocarcinoma Hit paper breakdown → | 2008 | 2237 |
| 15 | Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks Hit paper breakdown → | 2001 | 2139 |
| 16 | Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Hit paper breakdown → | 2018 | 2120 |
| 17 | Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers Hit paper breakdown → | 2013 | 2116 |
| 18 | OncoKB: A Precision Oncology Knowledge Base Hit paper breakdown → | 2017 | 1972 |
| 19 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Hit paper breakdown → | 2017 | 1970 |
| 20 | Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) Hit paper breakdown → | 2015 | 1754 |
About Marc Ladanyi
Marc Ladanyi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 750 papers that have together received 165.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (186 papers), Cancer Genomics and Diagnostics (157 papers), Sarcoma Diagnosis and Treatment (156 papers), Lymphoma Diagnosis and Treatment (51 papers), Genetic factors in colorectal cancer (40 papers), Renal and related cancers (36 papers), Lung Cancer Research Studies (35 papers) and Occupational and environmental lung diseases (30 papers). The work is most often cited by research in Cancer Research (39.9k citations), Pulmonary and Respiratory Medicine (62.5k citations), Oncology (50.8k citations), Pathology and Forensic Medicine (16.7k citations) and Molecular Biology (61.9k citations). Marc Ladanyi has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mark G. Kris, William J. Pao, Gregory J. Riely, María Juliana Arcila, Maureen Frances Zakowski, Cristina R. Antonescu, Vincent A. Miller, Pedram Argani, William L. Gerald and Natasha Rekhtman. Their work appears in journals such as Clinical Cancer Research, Journal of Thoracic Oncology, Modern Pathology, The American Journal of Surgical Pathology and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.